Oculis (OCSAW) Competitors $3.41 -0.72 (-17.43%) (As of 11/14/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends OCSAW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROWShould you be buying Oculis stock or one of its competitors? The main competitors of Oculis include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry. Oculis vs. 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Carmell Celularity CERo Therapeutics Oculis (NASDAQ:OCSAW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, community ranking, risk and media sentiment. Does the media favor OCSAW or ATNFW? In the previous week, Oculis and Oculis both had 1 articles in the media. Oculis' average media sentiment score of 1.89 beat 180 Life Sciences' score of 1.87 indicating that Oculis is being referred to more favorably in the media. Company Overall Sentiment Oculis Very Positive 180 Life Sciences Very Positive Is OCSAW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets OculisN/A N/A N/A 180 Life Sciences N/A N/A N/A Which has better valuation and earnings, OCSAW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOculisN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Does the MarketBeat Community prefer OCSAW or ATNFW? Oculis and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformOculisN/AN/A180 Life SciencesN/AN/A SummaryOculis beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Get Oculis News Delivered to You Automatically Sign up to receive the latest news and ratings for OCSAW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OCSAW vs. The Competition Export to ExcelMetricOculisBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$120.76M$5.38B$8.88BDividend YieldN/A3.71%4.99%4.03%P/E RatioN/A312.29127.4917.46Price / SalesN/A15,578.341,259.5193.02Price / CashN/A11.2439.4136.42Price / BookN/A7.616.295.86Net IncomeN/A-$12.95M$119.70M$225.23M7 Day Performance-31.80%10.06%-1.07%-0.88%1 Month Performance2.71%14.38%3.64%3.72%1 Year Performance152.59%31.29%36.57%26.42% Oculis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OCSAWOculisN/A$3.41-17.4%N/AN/A$0.00N/A0.0032Positive NewsGap DownATNFW180 Life SciencesN/A$0.01+8.8%N/A-19.1%$0.00N/A0.007Positive NewsGap UpSXTPW60 Degrees PharmaceuticalsN/A$0.01+0.8%N/A-78.3%$0.00$418,304.000.002Positive NewsDRTSWAlpha Tau MedicalN/A$0.20flatN/AN/A$0.00N/A0.0080News CoverageGap DownWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownAPLMWApollomicsN/A$0.01flatN/A-71.0%$0.00N/A0.0059Short Interest ↓Positive NewsBCTXWBriaCell TherapeuticsN/A$0.27-10.0%N/A-79.8%$0.00N/A0.008Short Interest ↓Gap DownCDIOWCardio DiagnosticsN/A$0.04+10.2%N/A-43.5%$0.00$39,138.000.007Positive NewsGap UpCTCXWCarmellN/A$0.11flatN/AN/A$0.00$12,320.000.009Positive NewsCELUWCelularityN/A$0.02+16.7%N/A-10.0%$0.00$33.52M0.00220Gap UpCEROWCERo TherapeuticsN/A$0.02+84.9%N/AN/A$0.00N/A0.008Short Interest ↓Positive NewsGap UpHigh Trading Volume Related Companies and Tools Related Companies ATNFW Alternatives SXTPW Alternatives DRTSW Alternatives WENAW Alternatives APLMW Alternatives BCTXW Alternatives CDIOW Alternatives CTCXW Alternatives CELUW Alternatives CEROW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OCSAW) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oculis Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Oculis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OCSAW Stock Alerts